EUVIMEDEUVIMED entdecken
Crossref

Aquaporin4-IgG seropositivity significantly increases the risk of comorbid autoimmune diseases in NMOSD patients: population-based registry data

Tatjana Pekmezovic, Vanja Jovicevic, Marko Andabaka, Nikola Momcilovic, Nikola Veselinovic, Olivera Tamas, Maja Budmkic, Stefan Todorovic, Marta Jeremic, Evica Dincic, Slobodan Vojinovic, Sladjana Andrejevic und 2 weitere

Journal of Neurology · 2024

DOI: 10.1007/s00415-024-12698-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurology, 2024. Verfasst von Tatjana Pekmezovic und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Epidemiology, Faculty of Medicine, University of Belgrade, 11000, Belgrade, Serbia. pekmezovic@sezampro.rs. Hauptthemen laut MEDLINE: Aquaporin 4, Neuromyelitis Optica, Registries, Autoimmune Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Wellcome Trust, Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The aim of our study was to estimate the frequency of autoimmune comorbidities, in NMOSD patients from the national Serbian NMOSD Registry. METHODS: Our study comprises 136 patients with NMOSD, diagnosed according to the NMOSD criteria 2015. At the time of the study, in the Registry were collected demographic and clinical data, including those related to the coexisting comorbidities and pathogenic autoantibodies. Not all patients were tested for all autoimmune antibodies. None of the seronegative aquaporin4-IgG (AQP4-IgG) NMOSD patients, included in the Registry, were positive for the myelin oligodendrocyte glycoprotein IgG. RESULTS: Among 136 NMOSD patients, 50 (36.8%) had at least one associated autoimmune disorder. AQP4-IgG was present in the sera from 106 patients (77.9%), the proportion of NMOSD patients with autoimmune comorbidities being significantly higher in the AQP4-IgG positive subgroup in comparison to the AQP4-IgG negative (p = 0.002). AQP4-IgG seropositive NMOSD patients had 5.2-fold higher risk of comorbid autoimmune diseases (OR = 5.2, 95% CI 1.4-18.5, p = 0.012). The most frequently reported diseases were autoimmune thyroid disease (15.4%), Sjogren's syndrome (11.0%), systemic lupus erythematosus (5.1%), myasthenia gravis (4.4%), and primary antiphospholipid antibody syndrome (2.9%). Antinuclear antibodies (ANAs) were frequently detected in the subgroup of NMOSD patients tested for this antibody (50/92; 54.3%). The higher frequency of ANAs and anti-extractable nuclear antigen autoantibodies, in the subgroups of AQP4-IgG-positive patients compared to the AQP4-IgG negative, tested for these antibodies, was statistically significant (p = 0.009, and p = 0.015, respectively). CONCLUSION: In conclusion, based on our results, in a defined cohort with European ethnical background, a wide spectrum of autoimmune diseases is frequently associated with AQP4-IgG seropositive NMOSD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aquaporin 4Neuromyelitis OpticaRegistriesAutoimmune DiseasesImmunoglobulin GComorbidityAutoantibodiesHumansFemaleMaleMiddle AgedAdultAgedSerbiaYoung Adult

Stichwörter der Autor:innen

Autoimmune comorbidityAutoimmune thyroid diseaseMyasthenia gravisNeuromyelitis optica spectrum disorderPathogenic autoantibodiesSjogren’s syndromeSystemic lupus erythematosus

Substanzen

Aquaporin 4Immunoglobulin GAQP4 protein, humanAutoantibodies

Autor:innen und Institutionen

  • Institute of Epidemiology, Faculty of Medicine, University of Belgrade, 11000, Belgrade, Serbia. pekmezovic@sezampro.rs.
  • Clinic of Neurology, University Clinical Center of Serbia, Belgrade, Serbia.
  • Institute of Epidemiology, Faculty of Medicine, University of Belgrade, 11000, Belgrade, Serbia.
  • Clinic of Neurology, Faculty of Medicine, Clinical Center Nis, University of Nis, Nis, Serbia.
  • Clinic of Neurology, Military Medical Academy, Medical Faculty, Defense University, Belgrade, Serbia.
  • Clinic of Allergology and Immunology, University Clinical Center of Serbia, Belgrade, Serbia.

Förderung

  • Wellcome Trust
  • Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja

Zitieren

APA

Pekmezovic, T., Jovicevic, V., Andabaka, M., Momcilovic, N., Veselinovic, N., Tamas, O., Budmkic, M., Todorovic, S., Jeremic, M., Dincic, E., Vojinovic, S., Andrejevic, S., Mesaros, S., & Drulovic, J. (2024). Aquaporin4-IgG seropositivity significantly increases the risk of comorbid autoimmune diseases in NMOSD patients: population-based registry data. Journal of Neurology. https://doi.org/10.1007/s00415-024-12698-2

Vancouver

Pekmezovic T, Jovicevic V, Andabaka M, Momcilovic N, Veselinovic N, Tamas O, et al. Aquaporin4-IgG seropositivity significantly increases the risk of comorbid autoimmune diseases in NMOSD patients: population-based registry data. Journal of Neurology. 2024. doi:10.1007/s00415-024-12698-2

BibTeX
@article{Pekmezovic2024,
  author = {Pekmezovic, Tatjana and Jovicevic, Vanja and Andabaka, Marko and Momcilovic, Nikola and Veselinovic, Nikola and Tamas, Olivera and Budmkic, Maja and Todorovic, Stefan and Jeremic, Marta and Dincic, Evica and Vojinovic, Slobodan and Andrejevic, Sladjana and Mesaros, Sarlota and Drulovic, Jelena},
  title = {Aquaporin4-IgG seropositivity significantly increases the risk of comorbid autoimmune diseases in NMOSD patients: population-based registry data},
  journal = {Journal of Neurology},
  year = {2024},
  doi = {10.1007/s00415-024-12698-2}
}
Kostenlos starten →